Overview Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular Hypertension Status: Completed Trial end date: 2016-03-01 Target enrollment: Participant gender: Summary Evaluation of the ocular hypotensive efficacy and safety of Netarsudil (AR-13324) Ophthalmic Solution compared to Timolol Maleate Ophthalmic Solution Phase: Phase 3 Details Lead Sponsor: Aerie PharmaceuticalsTreatments: Maleic acidOphthalmic SolutionsPharmaceutical SolutionsTimolol